InvestorsHub Logo
Followers 4
Posts 453
Boards Moderated 0
Alias Born 12/16/2019

Re: Retire43 post# 904

Monday, 12/19/2022 8:42:15 PM

Monday, December 19, 2022 8:42:15 PM

Post# of 1245
Interesting article. It was contributed by Chris Meeks... anyone know who that is?

Given the current dearth of simple/effective treatments for COVID, It's puzzling that BIXT isn't making more of a splash. Since Prolectin shows no toxicity or adverse side effects, you would think that countries like China and India would be fast-tracking approval of this drug.

I can see why the apparently corrupt FDA would slow walk any drug that would take market share from big Pharma but can't understand why countries with large at-risk populations and limited big Pharma influence wouldn't be knocking at BIXT's door.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIXT News